These two new products are the newest additions to Bio-Rad’s family of negative run controls and matrices in its molecular portfolio, which also includes the Exact Diagnostics Negative Run Control & Exact Diagnostics Bulk Negative (plasma), Exact Diagnostics STI Negative Run Control, Exact Diagnostics Synthetic Negative Run Control and Exact Diagnostics HAI Negative Run Control, the last three having been released late last year. The Exact Diagnostics Bulk CSF Negative is an independent external quality run control intended to monitor the absence of Anaplasma phagocytophilum, Babesia microti, Bartonella quintana, Borrelia burgdorferi, Ehrlichia chaffeensis, Enterovirus (EV), Herpes Simplex Virus-1 (HSV- 1), Herpes Simplex Virus-2 (HSV-2), and Varicella Zoster Virus (VZV) in various molecular assays. auris), Chlamydia trachomatis (CT), Cytomegalovirus (CMV), John Cunningham virus (JCV), Mycoplasma genitalium (MG), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Zika virus (ZKV) in various molecular assays. The Exact Diagnostics Bulk Urine Negative is intended to be validated as an independent external quality run control to monitor the absence of Adenovirus (ADV), BK virus (BKV), Candida auris ( C. These products may also help in the detection of errors in laboratory testing procedures, including potential contamination events. Both are matrices designed for spike-in or dilution purposes as well as to be used with molecular assays to monitor their intra- and inter-run performance. The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines.Bio-Rad Laboratories has expanded its molecular offering of quality controls with the launch of two new Exact Diagnostics products: Bulk Urine Negative and Bulk CSF Negative. On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that ’s writers disclose this fact and warn readers of the risks. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Why Is Greenlane (GNLN) Stock Down 90% Today?.PLTR Stock Alert: Palantir Announces Amazon Launch.GME Stock: 3 Things to Watch When GameStop Reports Earnings June 7.diagnostic solutions for hospitals, clinical, research and molecular labs. We’ve got all of that news ready to go with the following links! Randox provides clinical diagnostic solutions to laboratories worldwide and. InvestorPlace is home to all of the hottest stock market news traders need to know about on Tuesday! A few examples include why shares of GameStop GME, Palantir PLTR and Greenlane GNLN stock are on the move today. There’s even more stock market news worth reading about below! HTGM stock is down 42% as of Tuesday morning. That’s closing in on the company’s daily average trading volume of about 191,000 shares. As of this writing, more than 122,000 shares have changed hands. This has shares of HTGM stock seeing strong trading on Tuesday. The idea of the company going under has investors unsettled and many are selling their stakes as a result. It should come as no surprise that HTGM shares are falling today alongside the bankruptcy news. This has the company agreeing to pay Lawson $23,000. However, the company also signed a deal for his consulting services during a one-month transition period. That includes a $2.68 million loan held by Silicon Valley Bank, which is now a division of First-Citizens Bank and Trust Company.įinally, HTG Molecular Diagnostics clarified that it has terminated Senior Vice President and Chief Commercial Officer Byron Lawson at the start of the month. To go along with that, the filing also accelerates the obligations of the company’s debts. It’s also seeking a variety of first-day motions that will allow it to continue normal operations. HTG Molecular Diagnostics H HTGM stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing.Īccording to the filing, HTG Molecular Diagnostics will operate as a “debtor-in-possession” business during the bankruptcy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |